M chelonei M chelonei, sometimes called (with M fortuitum) the cold blooded tubercle bacillus, was originally isolated from a turtle.' It is often associated with cases of inoculation mycobacterioses2 and has recently been described as a cause of keratitis.' (In the review of the literature associated with the above report, the authors found at least 14 cases of keratitis or corneal ulcer due to M chelonei.) It M malmoense This is a very slow growing organism, often requiring up to 12 weeks incubation on egg media but growing more rapidly in the Bactec radiometric system.29 30 M malmoense was first described as a respiratory pathogen in 1977.3' Since then, it has been confirmed as a respiratory pathogen that often occurs in patients with pre-existing lung disease,32-34 causing a chronic infection that may be clinically indistinguishable from tuberculosis. In Edinburgh, we have also noted that the organism can cause a rapidly progressive lung disease, analogous to tuberculosis, in patients with no pre-existing lung disease (Crompton, personal communication) and that it may be isolated from a variety ofextrapulmonary sites including cervical lymph nodes, the urinary tract, the mouth, and bone. Disseminated disease and chronic skin sepsis have both been associated with the organism, usually in patients with underlying disease, often malignancy.35 -7 Henriques et al,35 in their review of 221 cases, noted that the organism was isolated from the respiratory tract in 171 patients, from cervical lymph nodes in 36 and from other sites in 10 (including urine, bone marrow and skin). (In six patients the original origin of the isolate was not known.) Many patients had underlying disease, but they too noted that pulmonary disease due to M malmoense could develop in previously healthy patients.
Little is known about the source ofthe organism; it is presumed to be, like many other mycobacteria, present "in the environment", but there is no detailed information available. In Edinburgh, we have some preliminary evidence of "clustering" of cases in certain geographical areas, but more data are required.
Interestingly, the organism is very seldom reported in HIV infected patients. M genavense Several authors have described the isolation of mycobacteria which, while growing in Bactec radiometric vials, were difficult or impossible to subculture or to grow on solid media.
Hirschel et al47 described fatal infection with a novel mycobacterium that was seen in postmortem smears, grew in the Bactec from several postmortem tissue homogenates, but could not be cultured on any ofthe test media, although it grew well in immunocompromised nude mice. Thin layer chromatography showed keto-mycolates (similar pattern to M simiae); gas chromatography showed tuberculostearic acid and hexadecanoic acid but no evidence of the secondary alcohols characteristic ofMAC. In 1992 Bottger et al48 described 18 patients with AIDS with disseminated mycobacterial infection with a demanding mycobacterium that they named "Mycobacerium genavense". The cultures of blood or tissues grew with difficulty in Bactec 13A vials in 16 patients, but the organism could not be subcultured onto solid media. All samples showed the same unique 16S ribosomal RNA sequence, demonstrating that the organism was a mycobacterium, that it differed from known mycobacterial species and that it was related to M simiae.
An organism showing an almost identical sequence was isolated from two patients with AIDS49 but, unlike earlier reports, was eventually subcultured onto Middlebrook 7H9 medium with added agar, charcoal and yeast extract after many attempts and after many months' incubation. The authors suggested that prolonged incubation on such media, possibly in an environment with added carbon dioxide, may permit isolation of other fastidious mycobacteria. We have had similar isolates from HIV positive patients and are endeavouring to subculture them; other reference centres are likely to have had similar experiences. Unfortunately, as these organisms have not been reliably subcultured, no information yet exists on their susceptibility to antimycobacterial agents.
The use of the Bactec radiometric technique has permitted the detection of such fastidious mycobacteria in body fluids including blood, although some authors claim that these techniques may underestimate the number of isolates of M genavense. 50 No doubt other fastidious mycobacteria will be isolated, especially in immunocompromised patients. Some of these may be new species, but it should not be forgotten that fastidious strains ofcommon mycobacteria occur. Jackson et al5' documented the isolation of a strain of M tuberculosis that would only grow on media deficient in glycerol.
Diagnosis and treatment On reviewing the literature, it is clear that a large number of mycobacteria have been isolated from patients with AIDS and from HIV negative patients, as well as from environmental sources. In addition to M tuberculosis and M avium a recent review52 lists a total of 21 species associated with HIV infection ( 12 weeks, rather than discarding them routinely at six weeks.
There is much work still to be done on the pathogenicity and susceptibility of these interesting organisms and proper clinical trials (probably multicentre) are an urgent necessity.
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